Advertisement
Screener

CRYOPORT, INC. (CYRX) Cost of Revenue

3.1 / 5 stars · 51/81 Roast Me

CRYOPORT, INC. Cost of Revenue

CRYOPORT, INC. (CYRX) reported Cost of Revenue of $26.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Cost of Sales

us-gaap:CostOfRevenue · last filed 2026-08-06

  • CRYOPORT, INC. cost of revenue for the quarter ending 2026-06-30 was $26.15M, a 8.60% increase year-over-year.
  • CRYOPORT, INC. cost of revenue for the quarter ending 2026-03-31 was $25.89M, a 15.56% increase year-over-year.
  • CRYOPORT, INC. cost of revenue for the quarter ending 2025-12-31 was $23.74M, a 8.11% increase year-over-year.
  • CRYOPORT, INC. cost of revenue for the quarter ending 2025-09-30 was $22.91M, a 9.71% increase year-over-year.
  • CRYOPORT, INC. cost of revenue for fiscal 2025 was $93.12M, a 6.90% increase from fiscal 2024.
  • CRYOPORT, INC. cost of revenue for fiscal 2024 was $87.11M, a 6.66% decline from fiscal 2023.
  • CRYOPORT, INC. cost of revenue for fiscal 2023 was $93.33M, a 30.04% decline from fiscal 2022.
  • CRYOPORT, INC. cost of revenue for fiscal 2022 was $133.40M, a 5.85% increase from fiscal 2021.
Period endCost of Revenue 3 monthCost of Revenue 3 month as first filedCost of Revenue 6 monthCost of Revenue 6 month as first filedCost of Revenue 9 monthCost of Revenue 9 month as first filedCost of Revenue 12 monthCost of Revenue 12 month as first filed
2026-06-30$26.15M
10-Q · filed 2026-08-06
$52.03M
10-Q · filed 2026-08-06
$75.77M
derived: sum of 3 quarters · filed 2026-08-06
$98.68M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$25.89M
10-Q · filed 2026-05-05
$49.62M
derived: sum of 2 quarters · filed 2026-05-05
$72.53M
derived: sum of 3 quarters · filed 2026-05-05
$96.61M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$23.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$46.65M
derived: sum of 2 quarters · filed 2026-03-05
$70.72M
derived: sum of 3 quarters · filed 2026-08-06
$93.12M
10-K · filed 2026-03-05
2025-09-30$22.91M
10-Q · filed 2025-11-06
$46.98M
derived: sum of 2 quarters · filed 2026-08-06
$69.38M
10-Q · filed 2025-11-06
$91.34M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$24.08M
10-Q · filed 2026-08-06
$46.48M
10-Q · filed 2026-08-06
$68.43M
derived: sum of 3 quarters · filed 2026-08-06
$89.31M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$22.40M
10-Q · filed 2026-05-05
$44.36M
derived: sum of 2 quarters · filed 2026-05-05
$65.24M
derived: sum of 3 quarters · filed 2026-05-05
$87.28M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$21.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$42.84M
derived: sum of 2 quarters · filed 2026-03-05
$64.89M
derived: sum of 3 quarters · filed 2026-03-05
$87.11M
10-K · filed 2026-03-05
$128.75M
10-K · filed 2025-03-07
2024-09-30$20.88M
10-Q · filed 2025-11-06
$31.28M
10-Q · filed 2024-11-07
$42.93M
derived: sum of 2 quarters · filed 2025-11-06
$65.15M
10-Q · filed 2025-11-06
$96.50M
10-Q · filed 2024-11-07
$58.56M
derived: sum of 4 quarters · filed 2026-03-05
2024-06-30$22.05M
10-Q · filed 2025-08-12
$32.41M
10-Q · filed 2024-08-08
$44.27M
10-Q · filed 2025-08-12
$65.22M
10-Q · filed 2024-08-08
$37.68M
derived: sum of 3 quarters · filed 2026-03-05
$69.57M
derived: sum of 4 quarters · filed 2026-03-05
2024-03-31$22.23M
10-Q · filed 2025-05-08
$32.82M
10-Q · filed 2024-05-08
$15.63M
derived: sum of 2 quarters · filed 2026-03-05
$47.52M
derived: sum of 3 quarters · filed 2026-03-05
$79.81M
derived: sum of 4 quarters · filed 2026-03-05
2023-12-31-$6.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$25.30M
derived: sum of 2 quarters · filed 2026-03-05
$57.58M
derived: sum of 3 quarters · filed 2026-03-05
$93.33M
10-K · filed 2026-03-05
$133.92M
10-K · filed 2024-03-13
2023-09-30$31.89M
10-Q · filed 2024-11-07
$64.18M
derived: sum of 2 quarters · filed 2024-11-07
$99.92M
10-Q · filed 2024-11-07
$134.00M
derived: sum of 4 quarters · filed 2025-03-07
2023-06-30$32.29M
10-Q · filed 2024-08-08
$68.03M
10-Q · filed 2024-08-08
$102.11M
derived: sum of 3 quarters · filed 2025-03-07
$136.16M
derived: sum of 4 quarters · filed 2025-03-07
2023-03-31$35.74M
10-Q · filed 2024-05-08
$69.83M
derived: sum of 2 quarters · filed 2025-03-07
$103.87M
derived: sum of 3 quarters · filed 2025-03-07
$139.19M
derived: sum of 4 quarters · filed 2025-03-07
2022-12-31$34.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07
$68.13M
derived: sum of 2 quarters · filed 2025-03-07
$103.44M
derived: sum of 3 quarters · filed 2025-03-07
$133.40M
10-K · filed 2025-03-07
2022-09-30$34.05M
10-Q · filed 2023-11-09
$69.36M
derived: sum of 2 quarters · filed 2023-11-09
$99.32M
10-Q · filed 2023-11-09
$132.65M
derived: sum of 4 quarters · filed 2024-03-13
2022-06-30$35.31M
10-Q · filed 2023-08-09
$65.28M
10-Q · filed 2023-08-09
$98.60M
derived: sum of 3 quarters · filed 2024-03-13
$131.78M
derived: sum of 4 quarters · filed 2024-03-13
2022-03-31$29.96M
10-Q · filed 2023-05-04
$63.29M
derived: sum of 2 quarters · filed 2024-03-13
$96.47M
derived: sum of 3 quarters · filed 2024-03-13
$127.26M
derived: sum of 4 quarters · filed 2024-03-13
2021-12-31$33.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13
$66.51M
derived: sum of 2 quarters · filed 2024-03-13
$97.30M
derived: sum of 3 quarters · filed 2024-03-13
$126.03M
10-K · filed 2024-03-13
2021-09-30$33.18M
10-Q · filed 2022-11-04
$63.97M
derived: sum of 2 quarters · filed 2022-11-04
$92.70M
10-Q · filed 2022-11-04
$121.17M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$30.79M
10-Q · filed 2022-08-04
$59.52M
10-Q · filed 2022-08-04
$87.99M
derived: sum of 3 quarters · filed 2023-02-28
$93.11M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$28.73M
10-Q · filed 2022-05-05
$57.20M
derived: sum of 2 quarters · filed 2023-02-28
$62.32M
derived: sum of 3 quarters · filed 2023-02-28
$66.58M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$28.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$33.58M
derived: sum of 2 quarters · filed 2023-02-28
$37.85M
derived: sum of 3 quarters · filed 2023-02-28
$42.36M
10-K · filed 2023-02-28
2020-09-30$5.12M
10-Q · filed 2021-11-04
$5.12M
10-Q · filed 2020-11-06
$9.38M
derived: sum of 2 quarters · filed 2021-11-04
$13.89M
10-Q · filed 2021-11-04
$13.89M
10-Q · filed 2020-11-06
$18.20M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$4.26M
10-Q · filed 2021-08-06
$4.26M
10-Q · filed 2020-08-10
$8.78M
10-Q · filed 2021-08-06
$8.78M
10-Q · filed 2020-08-10
$13.09M
derived: sum of 3 quarters · filed 2022-02-28
$18.04M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$4.52M
10-Q · filed 2021-05-06
$4.52M
10-Q · filed 2020-05-08
$8.83M
derived: sum of 2 quarters · filed 2022-02-28
$13.78M
derived: sum of 3 quarters · filed 2022-02-28
$17.91M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$4.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$9.27M
derived: sum of 2 quarters · filed 2022-02-28
$13.39M
derived: sum of 3 quarters · filed 2022-02-28
$16.59M
10-K · filed 2022-02-28
$16.59M
10-K · filed 2020-03-10
2019-09-30$4.96M
10-Q · filed 2020-11-06
$9.08M
derived: sum of 2 quarters · filed 2020-11-06
$12.28M
10-Q · filed 2020-11-06
$15.16M
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30$4.13M
10-Q · filed 2020-08-10
$7.32M
10-Q · filed 2020-08-10
$10.20M
derived: sum of 3 quarters · filed 2020-08-10
$12.75M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$3.20M
10-Q · filed 2020-05-08
$6.07M
derived: sum of 2 quarters · filed 2020-05-08
$8.62M
derived: sum of 3 quarters · filed 2020-05-08
$10.75M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31$2.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$5.42M
derived: sum of 2 quarters · filed 2020-03-10
$7.55M
derived: sum of 3 quarters · filed 2020-03-10
$9.39M
10-K · filed 2020-03-10
2018-09-30$2.55M
10-Q · filed 2019-11-12
$4.67M
derived: sum of 2 quarters · filed 2019-11-12
$6.51M
10-Q · filed 2019-11-12
$8.12M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$2.12M
10-Q · filed 2019-08-09
$3.96M
10-Q · filed 2019-08-09
$5.57M
derived: sum of 3 quarters · filed 2019-08-09
$6.97M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31$1.84M
10-Q · filed 2019-05-09
$3.45M
derived: sum of 2 quarters · filed 2019-05-09
$4.84M
derived: sum of 3 quarters · filed 2019-05-09
$6.37M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31$1.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
$3.00M
derived: sum of 2 quarters · filed 2019-03-13
$4.53M
derived: sum of 3 quarters · filed 2019-03-13
$5.99M
10-K · filed 2019-03-13
2017-09-30$1.40M
10-Q · filed 2018-11-08
$2.92M
derived: sum of 2 quarters · filed 2018-11-08
$4.38M
10-Q · filed 2018-11-08
$5.67M
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30$1.52M
10-Q · filed 2018-08-09
$2.98M
10-Q · filed 2018-08-09
$4.27M
derived: sum of 3 quarters · filed 2018-08-09
$5.45M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$1.46M
10-Q · filed 2018-05-03
$2.75M
derived: sum of 2 quarters · filed 2018-05-03
$3.93M
derived: sum of 3 quarters · filed 2018-05-03
$5.06M
derived: sum of 4 quarters · filed 2018-05-03
2016-12-31$1.29M
derived: 10-K 9 month − 10-Q 6 month · filed 2018-03-08
$2.47M
derived: sum of 2 quarters · filed 2018-03-08
$3.60M
10-K · filed 2018-03-08
$4.58M
10-K · filed 2018-03-08
2016-09-30$1.18M
10-Q · filed 2017-11-02
$2.32M
10-Q · filed 2016-11-14
$3.29M
10-Q · filed 2017-11-02
$4.36M
derived: sum of 4 quarters · filed 2017-11-02
2016-06-30$1.14M
10-Q · filed 2017-08-09
$2.11M
10-Q · filed 2017-08-09
$3.18M
derived: sum of 3 quarters · filed 2017-08-09
$4.18M
derived: sum of 4 quarters · filed 2017-08-09
2016-03-31$973.74K
10-Q · filed 2017-05-04
$2.05M
derived: sum of 2 quarters · filed 2017-05-04
$3.05M
derived: sum of 3 quarters · filed 2017-05-04
$3.99M
10-KT · filed 2017-03-13
2015-12-31$1.07M
10-Q · filed 2016-02-11
$2.07M
derived: sum of 2 quarters · filed 2016-11-14
$3.02M
10-KT · filed 2017-03-13
$3.85M
derived: sum of 4 quarters · filed 2016-11-14
2015-09-30$1.00M
10-Q · filed 2016-11-14
$1.94M
10-Q · filed 2016-11-14
$2.77M
derived: sum of 3 quarters · filed 2016-11-14
$3.51M
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$943.15K
10-Q · filed 2016-08-15
$1.77M
derived: sum of 2 quarters · filed 2016-08-15
$2.51M
derived: sum of 3 quarters · filed 2016-08-15
$3.11M
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31$828.47K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-28
$1.57M
derived: sum of 2 quarters · filed 2016-06-28
$2.17M
derived: sum of 3 quarters · filed 2016-06-28
$2.77M
10-K · filed 2016-06-28
2014-12-31$740.65K
10-Q · filed 2016-02-11
$1.34M
derived: sum of 2 quarters · filed 2016-02-11
$1.94M
10-Q · filed 2016-02-11
$2.63M
derived: sum of 4 quarters · filed 2016-02-11
2014-09-30$600.04K
10-Q · filed 2015-11-16
$1.20M
10-Q · filed 2015-11-16
$1.89M
derived: sum of 3 quarters · filed 2015-11-16
$2.48M
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30$597.23K
10-Q · filed 2015-08-06
$1.29M
derived: sum of 2 quarters · filed 2015-08-06
$1.88M
derived: sum of 3 quarters · filed 2015-08-06
$2.39M
derived: sum of 4 quarters · filed 2015-08-06
2014-03-31$691.68K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19
$1.28M
derived: sum of 2 quarters · filed 2015-05-19
$1.79M
derived: sum of 3 quarters · filed 2015-05-19
$2.22M
10-K · filed 2015-05-19
2013-12-31$590.27K
10-Q · filed 2015-02-05
$1.10M
derived: sum of 2 quarters · filed 2015-02-05
$1.53M
10-Q · filed 2015-02-05
$1.53M
derived: sum of 4 quarters · filed 2015-02-05
2013-09-30$507.73K
10-Q · filed 2014-11-12
$941.05K
10-Q · filed 2014-11-12
$941.57K
derived: sum of 3 quarters · filed 2014-11-12
$1.31M
derived: sum of 4 quarters · filed 2014-11-12
2013-06-30$433.32K
10-Q · filed 2014-07-31
$433.84K
derived: sum of 2 quarters · filed 2014-07-31
$802.64K
derived: sum of 3 quarters · filed 2014-07-31
$1.15M
derived: sum of 4 quarters · filed 2014-07-31
2013-03-31$521.00
10-K · filed 2013-06-25
$369.32K
derived: sum of 2 quarters · filed 2014-02-13
$713.76K
derived: sum of 3 quarters · filed 2014-02-13
$1.59M
10-K · filed 2014-06-25
2012-12-31$368.80K
10-Q · filed 2014-02-13
$713.24K
derived: sum of 2 quarters · filed 2014-02-13
$1.07M
10-Q · filed 2014-02-13
$1.07M
derived: sum of 4 quarters · filed 2014-02-13
2012-09-30$344.44K
10-Q · filed 2013-11-18
$698.06K
10-Q · filed 2013-11-18
$698.39K
derived: sum of 3 quarters · filed 2013-11-18
$698.73K
derived: sum of 4 quarters · filed 2013-11-18
2012-06-30$353.62K
10-Q · filed 2013-08-14
$353.95K
derived: sum of 2 quarters · filed 2013-08-14
$354.29K
derived: sum of 3 quarters · filed 2013-08-14
$354.66K
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31$330.00
10-K · filed 2013-06-25
$675.00
derived: sum of 2 quarters · filed 2013-06-25
$1.04K
derived: sum of 3 quarters · filed 2013-06-25
$1.39M
10-K · filed 2013-06-25
2011-12-31$345.00
10-K · filed 2013-06-25
$344.70K
10-Q · filed 2012-02-21
$709.00
derived: sum of 2 quarters · filed 2013-06-25
$1.06M
10-Q · filed 2013-02-14
$274.78K
derived: sum of 4 quarters · filed 2013-06-25
2011-09-30$364.00
10-K · filed 2013-06-25
$363.55K
10-Q · filed 2011-11-14
$717.83K
10-Q · filed 2012-11-09
$274.43K
derived: sum of 3 quarters · filed 2013-06-25
$530.96K
derived: sum of 4 quarters · filed 2013-06-25
2011-06-30$355.00
10-K · filed 2013-06-25
$354.28K
10-Q · filed 2011-08-15
$274.07K
derived: sum of 2 quarters · filed 2013-06-25
$530.59K
derived: sum of 3 quarters · filed 2013-06-25
$908.81K
derived: sum of 4 quarters · filed 2013-06-25
2011-03-31$273.71K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-27
$530.24K
derived: sum of 2 quarters · filed 2012-06-27
$908.45K
derived: sum of 3 quarters · filed 2012-06-27
$1.30M
10-K · filed 2012-06-27
2010-12-31$256.52K
10-Q · filed 2012-02-21
$634.74K
derived: sum of 2 quarters · filed 2012-02-21
$1.03M
10-Q · filed 2012-02-21
2010-09-30$378.22K
10-Q · filed 2011-11-14
$772.75K
10-Q · filed 2011-11-14
2010-06-30$394.54K
10-Q · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Apnimed, Inc. (APMD)United States$0.899B
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71